ArticleSeminars in hematology2021

Molecularly targeted therapies for relapsed and refractory peripheral T-cell lymphomas.

Zachary D Epstein-Peterson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.